FCN-207
/ Fosun Pharma, Fochon Pharmaceuticals
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 05, 2024
A Safety and Tolerability Study of FCN-207 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=132 | Completed | Sponsor: Fochon Pharmaceuticals, Ltd. | Recruiting ➔ Completed
Trial completion
1 to 1
Of
1
Go to page
1